Your browser doesn't support javascript.
loading
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
Maerevoet, Marie; Zijlstra, Josee M; Follows, George; Casasnovas, Rene-Olivier; Vermaat, J S P; Kalakonda, Nagesh; Goy, Andre; Choquet, Sylvain; Van Den Neste, Eric; Hill, Brian; Thieblemont, Catherine; Cavallo, Federica; De la Cruz, Fatima; Kuruvilla, John; Hamad, Nada; Jaeger, Ulrich; Caimi, Paolo; Gurion, Ronit; Warzocha, Krzysztof; Bakhshi, Sameer; Sancho, Juan-Manuel; Schuster, Michael; Egyed, Miklos; Offner, Fritz; Vassilakopoulos, Theodoros P; Samal, Priyanka; Ku, Matthew; Ma, Xiwen; Corona, Kelly; Chamoun, Kamal; Shah, Jatin; Shacham, Sharon; Kauffman, Michael G; Canales, Miguel.
Afiliación
  • Maerevoet M; Service Hématologie, Institut Jules Bordet, 1000, Brussels, Belgium. marie.maerevoet@bordet.be.
  • Zijlstra JM; Amsterdam UMC, Vrije Universiteit, Cancer Center, Amsterdam, Netherlands.
  • Follows G; Addenbrooke's Hospital, Cambridge, UK.
  • Casasnovas RO; Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France.
  • Vermaat JSP; LUMC, Leiden, Netherlands.
  • Kalakonda N; University of Liverpool, Liverpool, UK.
  • Goy A; Hackensack University Medical Center, Hackensack, USA.
  • Choquet S; Hôpital Pitié Salpêtrière, Paris, France.
  • Van Den Neste E; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Hill B; Cleveland Clinic, Cleveland, USA.
  • Thieblemont C; APHP, Hemato-oncology, Saint-Louis Hospital, Paris, France.
  • Cavallo F; Diderot University, Paris, France.
  • De la Cruz F; University of Torino, Turin, Italy.
  • Kuruvilla J; Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Hamad N; Princess Margaret Cancer Centre, Toronto, Canada.
  • Jaeger U; St. Vincent's Hospital Sydney, Darlinghurst, Australia.
  • Caimi P; Medical University of Vienna, Vienna, Austria.
  • Gurion R; UH Seidman Cancer Center, Cleveland, USA.
  • Warzocha K; Rabin MC, Petah Tiqwa, Israel.
  • Bakhshi S; Tel Aviv University, Tel Aviv, Israel.
  • Sancho JM; Instytut Hematologii I Transfuzjologii, Warsaw, Poland.
  • Schuster M; Dr. B. R. A. Institute Rotary Cancer Hospital, New Delhi, India.
  • Egyed M; Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.
  • Offner F; Stony Brook University Hospital Cancer Center, Stony Brook, USA.
  • Vassilakopoulos TP; Teaching Hospital Mór Kaposi, Kaposvár, Hungary.
  • Samal P; UZ Gent, Gent, Belgium.
  • Ku M; Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Ma X; Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
  • Corona K; St.Vincent's Hospital Melbourne, Fitzroy, Australia.
  • Chamoun K; Karyopharm Therapeutics, Newton, USA.
  • Shah J; Karyopharm Therapeutics, Newton, USA.
  • Shacham S; Karyopharm Therapeutics, Newton, USA.
  • Kauffman MG; Karyopharm Therapeutics, Newton, USA.
  • Canales M; Karyopharm Therapeutics, Newton, USA.
J Hematol Oncol ; 14(1): 111, 2021 07 16.
Article en En | MEDLINE | ID: mdl-34271963
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Triazoles / Linfoma de Células B Grandes Difuso / Hidrazinas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Triazoles / Linfoma de Células B Grandes Difuso / Hidrazinas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Bélgica